genespec private limited
Tender Performance & Track Record
Company Overview
Tender Performance
Data for 01 April 2024 to 18 June 2025
Total Bids / Contract Value
Qualified Bids / Q Rate
Total Wins / Win Value
Wins Rate / Q-W Rate
Detailed Performance Analysis
Tender Performance by Ministries
Name
Top Bid Competitors
Companies that frequently compete with you in the same tenders — ranked by their total win value.You applied for 6 bids — EUROFINS GENOMICS INDIA PRIVATE LIMITED appeared in 3 of them.
GENESPEC PRIVATE LIMITED
GENESPEC PRIVATE LIMITED
Financial Details
Registered Office
Building No. 33/702 Kuriyedath HouseNear Bhavans Vidhya Mandir ElamakkaraElamakkara-Ernakulam-Kerala-682026-India
Industry Classification
Business Services
Company Type
Market Information
Transform Your Tender Process
Join thousands of businesses winning more tenders
Smart Alerts
Get AI-powered tender recommendations
Market Intel
Track competitor bidding patterns
Email Reports
Weekly detailed analytics reports
Download Hub
Export tender data in bulk format
Smart Tracking
Never miss important deadlines
& Much More...
Discover all premium features with your trial
"TenderAI transformed our bidding process. We've increased our win rate by 40% and saved countless hours."
Historical Performance
7-year trend analysis (2018-2025)
Company Overview (1 Apr 2018-31 Mar 2025))
Total Bids
11
Contract Value
₹34.30 Lakh
L1 Bids
2
Recent Win Rate
33.3%
Performance Analytics
GENESPEC PRIVATE LIMITED: Comprehensive Tender Performance Analysis
Executive Summary:
GENESPEC PRIVATE LIMITED, a key player in the Indian genomics sector, has demonstrated mixed performance in government tenders. Over the period from April 2023 to March 2025, GENESPEC participated in 11 tenders, achieving a win rate of 18.2%. However, recent performance in FY2024-25 shows a significant improvement, with a win rate of 33.3%. The company's financial health, assessed by TenderAI, is currently rated as 'Concerning' with a score of 45.5/100, indicating areas for improvement in contract value and bid efficiency. Their engagement is primarily focused on the Ministry of Agriculture and Farmers Welfare, and the Department of Agricultural Research and Education (DARE).
GENESPEC's tender performance metrics reveal a growing presence in the government procurement landscape. Although the overall win rate from April 2018 to March 2025 stands at 18.2%, the company's qualification rate is 54.5%. This suggests potential for improvement in converting qualified bids into wins. Key industry terms for GENESPEC include "genomics supplier," "research provider," and "scientific vendor." The company's market positioning is currently challenging, requiring strategic interventions to enhance competitiveness. The Department of Agricultural Research and Education (DARE) is the primary department where GENESPEC excels, indicating a strong focus on agricultural research projects.
Financial Performance Analysis
Yearly Trends:
| Fiscal Year | Bid Count | Win Count | Qualification Rate | Win Rate | Total Contract Value |
|---|---|---|---|---|---|
| FY 2018-19 | 0 | 0 | 0.0% | 0.0% | ₹0 |